维普中文期刊产品整合服务
14篇 您的检索式:作者名="EMTESTAM"
    题名 作者 年代 出处 被引量
1Antibioticresistant Propionibacte- rium acnes on the skin of patients with moderate to severe acne in Stock- holm显示文摘Oprica C Emtestam L Lapins J 2004Anaerobe2004,10,3:1
2Studies on the relationship between vitamin D3 status and urinary excretion of calcium in healthy subjects:effects of increased levels of 25-hydroxyvitamin D3显示文摘BERLIN T EMTESTAM L BJORKHEM I 0,,46:1
3European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa显示文摘C.C. Zouboulis N. Desai L. Emtestam R.E. Hunger D. Ioannides I. Juhász J. Lapins L. Matusiak E.P. Prens J. Revuz S. Schneider‐Burrus J.C. Szepietowski H.H. Zee G.B.E. Jemec 2015J Eur Acad Dermatol Venereol2015,,4:1
4Increased nerve growth factor and tyrosine kinase A - like immuuoreactivities in pruri$o nodu- laris skinan exploration of the cause of neurohyperplasia 显示文摘Johansson O Liang Y Emtestam L 2002Arch Dermatol Res2002,293,:1
5Microbiology of hidradenitis suppurativa (acne inversa): a histological study of 27 patients显示文摘Anika C. Jahns Hassan Killasli Daniel Nosek Bertil Lundskog Anna Lenngren Zhanna Muratova Lennart Emtestam Oleg A. Alexeyev 2014APMIS2014,,9:1
6Increased nerve growth factor and tyrosine kinase A-like immunoreactivities in prurigo nodularis skinan exploration of the cause of neurohyperplasia显示文摘Johansson O Liang Y Emtestam L 2002Arch Dermatol Res2002,293,:1
7Angiokeratomas in Fabry's disease and Fordyce's disease: successful treatment with copper vapour laser显示文摘Lapins J Emtestam L Marcusson JA 1993Acta Derm Venereol1993,73,2:1
8Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma:a 5 year randomized trial显示文摘Basset-Seguin N Ibbotson SH Emtestam L 0,,05:1
9Increased nerve growth factor and tyrosine kinase A-like immuno-reactivities in prurigo nodularis ski:an exploration of the cause of neurohyperplasia显示文摘Johansson O Liang Y Emtestam L 2002Arch Dermatol Res2002,293,:1
10Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma:a 5 year randomized trial显示文摘Basset-Seguin N Ibbotson SH Emtestam L 2008Eur J Dermatol2008,18,5:1
11Angiokeratomasin Fabry's disease- and Fordyce's disease: successful treatment with copper vapour laser 显示文摘Lapins J Emtestam L Marcusson JA 1993ActaDeml Venereol1993,73,2:1
12Electrical impedance of nodular basal cell carcinoma:a pilot study显示文摘Emtestam L Nicander I Stenstrom M 1998Dermatology1998,197,4:1
13Correlation of impedanceresponse patterns to histologic findings in irritant skin reactions induced varioussurfactants显示文摘Nicarder I Ollmar S Eek A Rozell B L Emtestam L 1996Br J Dermatol1996,134,:1
14特应性皮炎患者中肿瘤的发病率显示文摘Objective: To assess the risk of skin cancer and other cancers among patients with atopic dermatitis. Design: Register- based retrospective cohort study. Setting: Sweden. Patients: A total of 15 666 hospitalized patients identified in the national Inpatient Register as having discharge diagnoses of atopic dermatitis between January 1, 1965, and December 31, 1999. Interventions: The National Swedish Cancer Register coded malignant neoplasms during the entire period of study. Follow- up time was calculated from the date of entry in the cohort until the occurrence of a first cancer diagnosis, emigration, death, or the end of the observation period, whichever occurred first. Main Outcome Measures: Follow- up by means of record linkages to several nationwide registers, among them the National Swedish Cancer Register. Standardized incidence ratios (SIRs) (the ratios of numbers of observed patients with cancer to expected numbers of incident cases of cancer) estimated the risk of developing cancer relative to the risks in the age- , sex- , and calendar year- matched general Swedish population. Results: After excluding the first year of follow- up, the risk of developing any cancer was increased by 13% (95% confidence interval [CI] of SIR, 1.01- 1.25, based on 311 observed patients with cancer). Excess risks were observed for cancers of the esophagus (SIR, 3.5; 95% CI, 1.3- 7.7; 6 patients), pancreas (SIR, 1.9; 95% CI, 1.0- 3.4; 11 patients), brain (SIR, 1.6; 95% CI, 1.1- 2.4; 27 patients), and lung (SIR, 2.0; 95% CI, 1.3- 2.8; 31 patients) and for lymphoma (SIR, 2.0; 95% CI, 1.4- 2.9; 29 patients). There was a nonsignificant 50% excess risk for nonmelanoma skin cancer (SIR, 1.5; 95% CI, 0.8- 2.6; 12 patients), seemingly confined to men and to the first 10 years of follow- up. Malignant melanoma did not occur more often than expected. Conclusions: The observed risk elevations, all of borderline statistical significance, should be interpreted cautiously. We could not control for possible confounding by cases of cancer caused by smoking, and the combination of multiple significance testing and few observed patients may have generated chance findings.Hagstrmer L. Ye W. Nyré n O. Emtestam L. 焦婷 2006世界核心医学期刊文摘(皮肤病学分册)2006,0,4:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费